Milestone Scientific Inc. (NYSEAMERICAN:MLSS) CFO Joseph D’agostino sold 52,980 shares of the business’s stock in a transaction on Wednesday, December 13th. The stock was sold at an average price of $1.05, for a total transaction of $55,629.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Joseph D’agostino also recently made the following trade(s):

  • On Tuesday, December 5th, Joseph D’agostino sold 15,000 shares of Milestone Scientific stock. The stock was sold at an average price of $1.05, for a total transaction of $15,750.00.

Milestone Scientific Inc. (MLSS) traded up $0.00 during trading hours on Friday, hitting $0.99. 16,179 shares of the stock traded hands, compared to its average volume of 77,328. Milestone Scientific Inc. has a one year low of $0.91 and a one year high of $1.80.

A number of research analysts have weighed in on the stock. Maxim Group reissued a “buy” rating and set a $4.00 target price on shares of Milestone Scientific in a research report on Wednesday, November 15th. ValuEngine raised shares of Milestone Scientific from a “sell” rating to a “hold” rating in a research report on Friday, September 8th.

ILLEGAL ACTIVITY NOTICE: This report was originally published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this report on another domain, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this report can be viewed at

Milestone Scientific Company Profile

Milestone Scientific Inc (Milestone) is engaged in providing computer-controlled injection technologies and solutions for the medical and dental markets. The Company uses its CompuFlo technology for the delivery of medicaments. The CompuFlo pressure or force Computer-Controlled Local Anesthetic Delivery (C-CLAD) technology is a medical technology for the delivery of drugs, anesthetics and other medicaments into various tissue types.

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with Analyst Ratings Network's FREE daily email newsletter.